133 related articles for article (PubMed ID: 15041079)
1. Transforming growth factor-beta (TGF-beta)-resistant B cells from chronic lymphocytic leukemia patients contain recurrent mutations in the signal sequence of the type I TGF-beta receptor.
Schiemann WP; Rotzer D; Pfeifer WM; Levi E; Rai KR; Knaus P; Kadin ME
Cancer Detect Prev; 2004; 28(1):57-64. PubMed ID: 15041079
[TBL] [Abstract][Full Text] [Related]
2. The effect of FK506 on transforming growth factor beta signaling and apoptosis in chronic lymphocytic leukemia B cells.
Romano S; Mallardo M; Chiurazzi F; Bisogni R; D'Angelillo A; Liuzzi R; Compare G; Romano MF
Haematologica; 2008 Jul; 93(7):1039-48. PubMed ID: 18492692
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of resistance to growth inhibition by transforming growth factor-beta 1 (TGF-beta 1) in primary lung cancer and new molecular targets in therapy].
Gemma A; Uematsu K; Hagiwara K; Takenoshita S; Kudoh S
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1253-9. PubMed ID: 10945024
[TBL] [Abstract][Full Text] [Related]
4. Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells.
Yang HK; Kang SH; Kim YS; Won K; Bang YJ; Kim SJ
Oncogene; 1999 Apr; 18(13):2213-9. PubMed ID: 10327067
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas.
Chen T; Triplett J; Dehner B; Hurst B; Colligan B; Pemberton J; Graff JR; Carter JH
Cancer Res; 2001 Jun; 61(12):4679-82. PubMed ID: 11406536
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling.
Shimanuki T; Hara T; Furuya T; Imamura T; Miyazono K
Oncogene; 2007 May; 26(23):3311-20. PubMed ID: 17146441
[TBL] [Abstract][Full Text] [Related]
7. Redirection of B cell responsiveness by transforming growth factor beta receptor.
Roes J; Choi BK; Cazac BB
Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7241-6. PubMed ID: 12773615
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta and its receptor complex in leukemic B-cell precursors.
Buske C; Becker D; Feuring-Buske M; Hannig H; Griesinger F; Hiddemann W; Wörmann B
Exp Hematol; 1998 Nov; 26(12):1155-61. PubMed ID: 9808055
[TBL] [Abstract][Full Text] [Related]
9. A transforming growth factor-beta receptor-interacting protein frequently mutated in human ovarian cancer.
Ding W; Tang Q; Espina V; Liotta LA; Mauger DT; Mulder KM
Cancer Res; 2005 Aug; 65(15):6526-33. PubMed ID: 16061631
[TBL] [Abstract][Full Text] [Related]
10. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
11. Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia.
DeCoteau JF; Knaus PI; Yankelev H; Reis MD; Lowsky R; Lodish HF; Kadin ME
Proc Natl Acad Sci U S A; 1997 May; 94(11):5877-81. PubMed ID: 9159168
[TBL] [Abstract][Full Text] [Related]
12. Expression of TGF-beta1 and its receptor genes (TbetaR I, TbetaR II, and TbetaR III-betaglycan) in peripheral blood leucocytes in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome.
Jachec W; Foremny A; Domal-Kwiatkowska D; Smolik S; Tomasik A; Mazurek U; Wodniecki J
Int J Mol Med; 2008 Jan; 21(1):99-107. PubMed ID: 18097622
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer.
Chen T; Carter D; Garrigue-Antar L; Reiss M
Cancer Res; 1998 Nov; 58(21):4805-10. PubMed ID: 9809982
[TBL] [Abstract][Full Text] [Related]
14. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta control of cell proliferation.
Huang SS; Huang JS
J Cell Biochem; 2005 Oct; 96(3):447-62. PubMed ID: 16088940
[TBL] [Abstract][Full Text] [Related]
16. Alkylator resistance in human B lymphoid cell lines: (2). Increased levels of topoisomerase II expression and function in a melphalan-resistant B-CLL cell line.
Pu QQ; Bezwoda WR
Anticancer Res; 2000; 20(4):2569-78. PubMed ID: 10953328
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling demonstrates that TGF-beta1 signals exclusively through receptor complexes involving Alk5 and identifies targets of TGF-beta signaling.
Karlsson G; Liu Y; Larsson J; Goumans MJ; Lee JS; Thorgeirsson SS; Ringnér M; Karlsson S
Physiol Genomics; 2005 May; 21(3):396-403. PubMed ID: 15769904
[TBL] [Abstract][Full Text] [Related]
18. Glioma gene therapy with soluble transforming growth factor-beta receptors II and III.
Naumann U; Maass P; Gleske AK; Aulwurm S; Weller M; Eisele G
Int J Oncol; 2008 Oct; 33(4):759-65. PubMed ID: 18813789
[TBL] [Abstract][Full Text] [Related]
19. Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells.
Garrigue-Antar L; Muñoz-Antonia T; Antonia SJ; Gesmonde J; Vellucci VF; Reiss M
Cancer Res; 1995 Sep; 55(18):3982-7. PubMed ID: 7664267
[TBL] [Abstract][Full Text] [Related]
20. Rapid closure of midgestational excisional wounds in a fetal mouse model is associated with altered transforming growth factor-beta isoform and receptor expression.
Goldberg SR; McKinstry RP; Sykes V; Lanning DA
J Pediatr Surg; 2007 Jun; 42(6):966-71; discussion 971-3. PubMed ID: 17560204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
